An Experience of Health Technology Assessment in New Models of Care for Subjects with Parkinson’s Disease by Means of a New Wearable Device

Daniele Giansanti; Giovanni Maccioni; Sandra Morelli
June 2008
Telemedicine & e-Health;Jun2008, Vol. 14 Issue 5, p467
Academic Journal
This report characterizes a system combining gastrocnemius expansion measurement unit (GEMU), a step-counting device, with a telemedicine application for patients with Parkinsonism. GEMU by telemedicine correlated strongly with motion decrement in a robust and reliable system, which enjoyed high user acceptance.


Related Articles

  • Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease.  // Neurochemical Research;Mar2008, Vol. 33 Issue 3, p589 

    Abstract  Environmental toxins, genetic predisposition and old age are major risk factors for Parkinson’s disease (PD). Although the mechanism(s) underlying selective dopaminergic (DA) neurodegeneration remain unclear, molecular studies in both toxin based models and...

  • The Multiple Tasks Test. Strategies in Parkinson's disease. Bloem, Bastiaan R.; Valkenburg, Vibeke V.; Slabbekoorn, Mathilde; van Dijk, J. Gert // Experimental Brain Research;Apr2001, Vol. 137 Issue 3/4, p478 

    The clinical balance tests presently used cannot predict falls in Parkinson's disease (PD), perhaps because they probe fairly isolated "components" of postural control. The Multiple Tasks Test (MTT) is a new balance test that simultaneously assesses multiple components of postural control. We...

  • Induction of parkinsonian resting tremor by stimulation of the caudal zona incerta nucleus: a clinical study. Plaha, P.; Filipovic, S.; Gill, S. S. // Journal of Neurology, Neurosurgery & Psychiatry;May2008, Vol. 79 Issue 5, p514 

    Introduction: We hypothesise that parkinsonian tremor arises when the caudal zona incerta (cZI) and subthalamic nucleus (STN) are deprived of dopamine and become increasingly responsive to motor cortical and β frequency oscillations. These oscillations are synchronised and amplified through...

  • Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions. Bosch-Bouju, Clémentine; Hyland, Brian I.; Parr-Brownlie, Louise C. // Frontiers in Computational Neuroscience;Nov2013, p1 

    Motor thalamus (Mthal) is implicated in the control of movement because it is strategically located between motor areas of the cerebral cortex and motor-related subcortical structures, such as the cerebellum and basal ganglia (BG). The role of BG and cerebellum in motor control has been...

  • The relationship between Parkinson's disease and dementia. A study using proton NMR imaging parameters. Besson, J. A. O.; Mutch, W. J.; Smith, F. W.; Corrigan, F. M.; Besson, J A // British Journal of Psychiatry;Oct85, Vol. 147, p380 

    The value of the spin lattice relaxation time (T1) obtained during nuclear magnetic resonance imaging of the brain was studied in patients with idiopathic Parkinson's disease, with and without dementia. T1 increases significantly in the basal ganglia and cerebral white matter of the demented and...

  • Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice. Pan-Montojo, Francisco; Anichtchik, Oleg; Yanina Dening; Knels, Lilla; Pursche, Stefan; Roland Jung; Jackson, Sandra; Gille, Gabriele; Spillantini, Maria Grazia; Reichmann, Heinz; Funk, Richard H. W. // PLoS ONE;2010, Vol. 5 Issue 1, p1 

    In patients with Parkinson's disease (PD), the associated pathology follows a characteristic pattern involving inter alia the enteric nervous system (ENS), the dorsal motor nucleus of the vagus (DMV), the intermediolateral nucleus of the spinal cord and the substantia nigra, providing the basis...

  • Nucleotide metabolism is key in Parkinson's disease, study shows. Kingman, Sharon // BioWorld Today;1/23/2014, Vol. 25 Issue 15, p1 

    The article focuses on the understanding of Nucleotide metabolism which can help in preventing Parkinson's disease. Topics discussed include this can provide fresh targets for possible anticancer treatments, researchers have found that a network of genes which have been involved in the synthesis...

  • Complications of percutaneous endoscopic gastrostomy-jejunostomy for levodopa/ carbidopa infusion in advanced Parkinson's disease. Olivares, Ana; Collado, David; Muñoz-Navas, Miguel; Calvo, Marta; Olivo, Eduardo; Chico, Inmaculada; Marra, Carlos; Sánchez-Estella, Rafael; Rodríguez, Sarbelio; Subtil, Josè Carlos; Rábago, Luis Ramon // Gastroenterology Insights;2012, Vol. 4 Issue 2, p13 

    Continuous infusions of levodopa directly into the duodenum-yeyunum is an effective therapy to reduce daily off time in an advanced stage of Parkinson's disease, but it is not without complications, particularly device related problems. We present our experience in three Spanish hospitals with...

  • The Postencephalitic Parkinson Syndrome. Livingston Hunt, Edward; Cornwall, Leon H. // JAMA: Journal of the American Medical Association;4/23/2014, Vol. 311 Issue 16, p1696 

    The article discusses the results of a study of postencephalitic Parkinson syndrome. Topics discussed include the indications of the parkinsonian syndrome including typical lesions of encephalitis, hemorrhages and areas of degeneration, three major and several minor symptoms including rigidity,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics